Details for New Drug Application (NDA): 019326
✉ Email this page to a colleague
NDA 019326 describes SYNOVALYTE IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and is included in one NDA. Additional details are available on the SYNOVALYTE IN PLASTIC CONTAINER profile page.
The generic ingredient in SYNOVALYTE IN PLASTIC CONTAINER is magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate. There are one hundred and forty-six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate profile page.
The generic ingredient in SYNOVALYTE IN PLASTIC CONTAINER is magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate. There are one hundred and forty-six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate profile page.
Summary for 019326
| Tradename: | SYNOVALYTE IN PLASTIC CONTAINER |
| Applicant: | Baxter Hlthcare |
| Ingredient: | magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;IRRIGATION | Strength | 30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML | ||||
| Approval Date: | Jan 25, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
